CommScope Holding Company, Inc. (COMM) EPS Estimated At $0.33; Akcea Therapeutics (AKCA) SI Increased By 4.78% The FinHeadLines
Akcea Therapeutics Inc (NASDAQ:AKCA) had an increase of 4.78% in short interest. AKCA’s SI was 8.09M shares in January as released by FINRA.